Coronavirus vaccine being developed by China will be available to the general public by November, an officer at the Center for Disease Control and Prevention (CDC) said. Let us tell you that the research is underway on four COVID-19 vaccines in China. These are in the last stage of the clinical trials.
The emergency program was started in July. CDC’s Chief Biosafety Expert Wu Guizhen said in a conversation with the state TV channel, “I myself took part in a trial in April. No side effects have been revealed so far.”
Sinopharm, and Sinovac Biotech companies conducting research on three vaccines:
Wu, however, did not state that she was referring to any vaccine. Let us tell you that Sinopharm and Sinovac Biotech companies are conducting research on three vaccines. The fourth vaccine is being developed by the CanSino Biologics Company.
The Chinese army approved the vaccine in June. Sinopharm said in July that its vaccine would be available in the market by the end of this year. Its third phase trials are underway.
China: 8 new cases reported in the last 24 hours
China reported 8 new cases on Monday. Earlier, 10 cases were reported on Sunday. The National Health Authority gave this information on Tuesday. However, the health body also made it clear that no new cases of infection have been reported inside the country.
That is, all the new cases are imported. Talking about statistics, a total of 85,202 cases have been reported in China so far, while 4,634 patients have died.
Lockdown in Israel again:
Israeli Prime Minister Benjamin Netanyahu announced a nationwide lockdown for three weeks on Sunday. This lockdown will come into effect from Friday. With this, Israel has become the first country in the world to re-impose lockdown restrictions.
During this time, people will have to live within 500 meters of their house. However, they can go to work for a limited time. Cases are increasing in the country. So far, 1,55,604 people have been infected and 1119 deaths have also been reported.